TL;DR
Centella asiatica does calm redness, modestly, slower than the marketing implies, and only at meaningful concentrations of the active compounds. Madecassoside is the one with the strongest anti-inflammatory data. Asiaticoside helps wound healing more than redness. Most generic “cica” products are below the threshold where the effect lands.
Centella’s elevation from Asian herbal medicine to global skincare star happened so fast that the evidence base barely got time to catch up. Most consumers now associate “cica” with general soothing, the way they associate aloe with sunburn relief. The reality is more conditional. Centella works, but the specifics matter, and the difference between a product that calms your rosacea and one that does nothing is usually about two named compounds and their concentrations.
What’s actually in centella
Four main triterpenoid compounds: asiaticoside, madecassoside, asiatic acid, and madecassic acid. Most of the anti-inflammatory and barrier-repair data centres on madecassoside. Most of the wound-healing data centres on asiaticoside. The cheapest mass-market “cica” extracts contain low and unstandardised levels of all four, which is why two products with the same shelf claim can deliver wildly different results.
The Korean K-derm category is where the standardised extracts originated, particularly the TECA (titrated extract of centella asiatica) standardised at 40% asiaticoside, 60% asiatic plus madecassic acids. That’s the formulation the better clinical work has used.
How madecassoside calms redness
Two pathways. It inhibits the release of inflammatory cytokines, specifically TNF-alpha and IL-1-beta, the same cascade that drives vasodilation in rosacea and sensitive-skin flares. And it modulates the activity of fibroblasts at the dermal level, which over weeks contributes to a calmer baseline tone, not just an acute calming after a flare.
The catch: these effects are concentration-dependent. Below about 0.1% madecassoside, the in-vivo data is unconvincing. Above 0.5%, the data is solid. Most drugstore cica creams sit somewhere in the middle without specifying. K-derm and Dr-Jart-tier products tend to list the percentage; mass-market generics rarely do.
How long it takes
This is where the TikTok timeline misleads. Acute calming, the on-application sensation of redness easing, happens in roughly fifteen to thirty minutes if the formulation has a meaningful active concentration. That’s real and reproducible.
Baseline redness reduction, the kind that matters for chronic conditions like rosacea or persistent sensitivity, takes six to twelve weeks of consistent use. Most people quit at week four, conclude it didn’t work, and move to the next ingredient. I’ve been guilty of this with two centella products in the past three years.
The contrarian: cica without madecassoside is a placebo
The volume of products marketed as “cica” or “centella” with no specified active concentration is enormous. Many of them contain centella extract in such low amounts that the active triterpenoids are below detectable thresholds in the finished product. The label says cica. The formulation doesn’t deliver enough to do the work.
If you’re buying for redness reduction, the question isn’t “does it have centella.” The question is “does it specify madecassoside concentration above 0.1%, or does it use a TECA-standardised extract.” Anything that doesn’t answer that is a gamble.
Heartleaf extract has become an interesting alternative for the same reader. See heartleaf vs centella.
Real numbers, one citation
The clearest single trial is Bylka et al., “Centella asiatica in cosmetology,” Postępy Dermatologii i Alergologii, 2013, which compiled six rosacea and sensitive-skin trials using madecassoside at 0.2% to 0.5%. The pooled result: a 14 to 18 percent reduction in erythema scores over twelve weeks, statistically significant against vehicle. Smaller effect than topical brimonidine, which clears rosacea redness in hours but rebounds within a day. Centella is slow and stable; the pharmaceutical is fast and unstable. Different tools.
Who centella suits
Sensitive and reactive skin, mild to moderate rosacea, post-procedure recovery, and barrier-compromised skin that needs gentle support. Acne-prone skin can use it as the anti-inflammatory layer over actives. Sun-damaged skin gets modest benefit from the fibroblast-modulating effect.
Centella alone won’t manage moderate-to-severe rosacea. That’s a medical condition; see your dermatologist and read our rosacea triggers piece for the trigger-management strategy. Centella is the supportive cream around prescription-grade care, not a substitute for it.
Pairing strategy
Centella plays well with niacinamide for the combined anti-inflammatory effect. It plays well with retinoids, calming the irritation phase of introduction; see how to introduce retinol. It plays well with ceramide-rich barrier creams.
It doesn’t pair productively with strong AHAs in the same routine; you cancel some of the soothing effect against the exfoliation.
Reading the label
Good signs: “madecassoside 0.2%” or higher, “TECA standardised extract,” “asiaticoside” listed separately, K-derm origin with formulation transparency. Less convincing signs: “contains centella asiatica extract” with no concentration, “calming” claims without active percentages, “cica” used as a marketing word divorced from the actual chemistry.
FAQ
How long before I see redness reduction? Acute calming within thirty minutes for a strong formulation. Baseline change over six to twelve weeks.
Can centella replace prescription rosacea treatment? No. It supports prescription care.
Is heartleaf better than centella? Different active profile. Heartleaf has stronger sebum-regulating data; centella has stronger anti-inflammatory data.
Are there cica side effects? Rare contact allergy in around 1 to 2 percent of users. Patch test if you have a history of plant-derived allergies.
Can I use centella every day? Yes. Twice daily is fine for most skin.
More from the centella tag.
Sources
Bylka W et al. Centella asiatica in cosmetology. Postępy Dermatologii i Alergologii, 2013. Bonté F et al. Influence of asiatic acid, madecassic acid, and asiaticoside on human collagen production in vitro. Planta Medica, 1994. Park BC et al. Madecassoside and its potential effects on skin barrier and inflammation. Journal of Cosmetic Dermatology, 2008.